Besides, the Kaplan-Meier survival curve revealed that the OS and progression-free survival of patients with POLE2 high expression was significantly lower than that of patients with POLE2 low expression (Figure 1H and Supplementary Figure 1B), which suggested that the expression of POLE2 in RCC tissues was negatively associated with prognosis. Here, POLE2 is linked to renal cell carcinoma.